The role and mechanism of NRF2 in endothelial cells and smooth muscle cells of pulmonary artery
S. Ning, X. Guo, Y. Zhu, C. Li, R. Li, Y. Meng, W. Luo, D. Lu, Y. Yupeng
Abstract
Pulmonary hypertension (PH) is a kind of fatal disease. There are no existing drugs that could reverse the diseas. NF-E2-related factor 2 (NRF2) is one of the most important moleculars in the range of cell protection. We examined the expression of NRF2 in PH models and explored the role of NRF2 in regulating abnormal phenotypes in pulmonary artery cells. We determined the expression level of NRF2 in lung tissues of PH model decreased significantly. We found that NRF2 was reduced in rat pulmonary artery endothelial cells (rPAEC) under hypoxia, while it was overexpressed in rat pulmonary artery smooth muscle cells (rPASMC) under hypoxia. Next, the results showed that knockdown NRF2 in rPAEC promoted endothelial-mesenchymal transformation and upregulated reactive oxygen species level. After the rPASMC was treated with siRNA or activator, we found that NRF2 could promote cell proliferation by regulating PDGFR/ERK1/2 and mTOR/P70S6K pathways, and accelerate cell migration by affecting MMP2/3/7. Therefore, the study suggests that the combination of NRF2 activators should be considered to eliminate the promoting effect of NRF2 activators on proliferation and migration of rPASMC. Summary statementHypoxia regulates NRF2 in PAECs and PASMCs differently. We found that NRF2 could promote cell proliferation by regulating PDGFR/ERK1/2 and mTOR/P70S6K pathways, and accelerate cell migration by affecting MMP2/3/7.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Role of EBP50 in Regulating Endothelial-To-Mesenchymal Transition in Pulmonary Hypertension
A. Gorelova, M. Berman, … I. Al Ghouleh·bioRxiv·May 31, 2022
- The Unexpected Role of GCN2 Kinase Activation in Mediating Pulmonary Vascular Remodeling and Pulmonary Arterial Hypertension
M. M. Zhu, J. Dai, … Y.-Y. Zhao·bioRxiv·Sep 5, 2023
- PPARγ/ETV2 Axis Regulates Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
D. H. Lee, M. Kim, … B.-Y. Kang·bioRxiv·May 17, 2022
- ARF6 as a novel activator of HIF-2alpha in pulmonary arterial hypertension
A. L. Fellows, C.-N. Chen, … B. Wojciak-Stothard·bioRxiv·Sep 15, 2023
- Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α
Shuibang Wang, Keytam S. Awad, … Robert L. Danner·American Journal of Physiology-Lung Cellular and Molecular PhysiologyPeer-reviewed·Aug 19, 2024
- E2F1 Drives Endothelial Arterial Programming in Pulmonary Arterial Hypertension
Dan Yi, Ankit Tripathi, … Zhiyu Dai·bioRxiv·Jul 7, 2026